熱門資訊> 正文

Veraderspel报告第二季度业绩

2026-08-11 19:36

Veradermics(MANE) 0
VDO-PH INTL(VDPH) 0

Veradermics press release (MANE): Q2 Net loss was $23.5 million as compared to a net loss of $15.6 million for the second quarter of 2025.
Cash, cash equivalents and marketable securities of $819.9 million as of June 30, 2026, expected to fund operations into 2030 through multiple Phase 3 readouts and potential commercial launch of VDPHL01.

More on Veradermics

Veradermics: Wait For The Post-Lockup, But Buy Before The Roll-Up
Veradermics, Incorporated (MANE) Discusses Positive Female Results From Phase II Study of VDPHL01 for Pattern Hair Loss - Slideshow
Veradermics: VDPHL01 Looks Promising Enough On Paper
Veradermics jumps after mid-stage trial data for lead drug in female pattern hair loss
Historical earnings data for Veradermics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。